INSIGHTS

Pharmana Wider View Vol.2 – Cardiovascular Disease https://manadvisory.com/wp-content/themes/movedo/images/empty/thumbnail.jpg 150 150 mana mana https://secure.gravatar.com/avatar/6cf6ef8dcdf39a9d8adec41bb1765d31?s=96&d=mm&r=g August 5, 2019 August 6, 2019

mana
August 5, 2019
No Comments
Mana, Mana Insights, Newsletter, Pharmana, Pharmana Insights

Pharmana Wider View Vol.2 – Cardiovascular Disease

PHARMANA WIDER VIEW - August 2019 Vol2 Cardiovascular disease (CVD), or heart disease, is an umbrella term that includes all conditions affecting the heart. By 2020, 50 percent of global health care expenditures – about $4 trillion – will be spent on three leading causes of death: cardiovascular diseases, cancer and respiratory diseases. According to…

Pharmaceutical Stock Market Analaytics https://manadvisory.com/wp-content/uploads/2018/10/blog.jpg 1900 410 mana mana https://secure.gravatar.com/avatar/6cf6ef8dcdf39a9d8adec41bb1765d31?s=96&d=mm&r=g April 6, 2019 April 6, 2019

mana
April 6, 2019
No Comments
Mana Events, Pharmana, Pharmana Reports

Pharmaceutical Stock Market Analaytics

Pharmaceutical Stock Market Analaytics Due to the lack of coherent information from Iranian pharmaceutical market and in order to meet this industry’s need, we play our role at Pharmana Group by collecting and categorizing available data of the stock exchange in the Iranian pharmaceutical industry, and revising the stock changes and the companies’ trend. So…

Iranian Pharmaceutical Market and Industry Analysis https://manadvisory.com/wp-content/uploads/2018/10/search.jpg 1900 410 mana mana https://secure.gravatar.com/avatar/6cf6ef8dcdf39a9d8adec41bb1765d31?s=96&d=mm&r=g January 7, 2019 April 6, 2019

mana
January 7, 2019
No Comments
Mana Events, Pharmana, Pharmana Reports

Iranian Pharmaceutical Market and Industry Analysis

Iranian Pharmaceutical Market and Industry Analysis Due to Iran’s untapped health market and its capabilities (especially pharmaceutical market), improvement of environmental factors, recent international agreements, health transformation plan and governmental policies for supporting foreign investment serious actions have been taken by domestic and international players and investors to consider Iran’s Market. Lack of accumulation of…

There are thousands of us now! https://manadvisory.com/wp-content/uploads/2018/05/hesemehr-1000-resized310-tinypng.jpg 310 310 ali ali https://secure.gravatar.com/avatar/02fabad9e3e26c2130ceb317e9b97fcc?s=96&d=mm&r=g November 12, 2018 February 18, 2019

ali
November 12, 2018
No Comments
Mana, Mana Events

There are thousands of us now!

We are going to celebrate the feast of being Thousands. With the support of your love, and our cooperation with state hospitals throughout Iran, today we identified a thousand children in need of help. And with your kind hands, we have painted a sweet smile on the lips of more than 700 lovely children. Stay…

The visit of ministry of health from Hese-Mehr https://manadvisory.com/wp-content/uploads/2018/10/hesemehr-1.png 220 228 ali ali https://secure.gravatar.com/avatar/02fabad9e3e26c2130ceb317e9b97fcc?s=96&d=mm&r=g October 21, 2018 January 7, 2019

ali
October 21, 2018
No Comments
Mana, Mana Events

The visit of ministry of health from Hese-Mehr

The visit of ministry of health from Hese - Mehr The visit of Dr. Hashemi, Minister of Health and Medical Affairs, and Mr. Ayazi, Deputy Minister of Social Affairs of the Ministry of Health, from the Hese-Mehr booth at the Digital Media Festival. In this visit, he expressed his satisfaction for the establishment of a…

Pharmana Wider View Vol.1 – Dementia https://manadvisory.com/wp-content/themes/movedo/images/empty/thumbnail.jpg 150 150 ali ali https://secure.gravatar.com/avatar/02fabad9e3e26c2130ceb317e9b97fcc?s=96&d=mm&r=g May 25, 2018 August 5, 2019

ali
May 25, 2018
No Comments
Mana, Mana Insights, Newsletter, Pharmana, Pharmana Insights

Pharmana Wider View Vol.1 – Dementia

PHARMANA WIDER VIEW - July 2019 Vol1 The global Alzheimer’s drugs market is going to grow at a CAGR of 1.90% during the period 2017-2021 with Key vendors being Allergan, Eisai Pharmaceuticals, Johnson & Johnson, and Novartis, with other prominent vendors Amgen and Pfizer. Much of the increase will be in developing countries. Already 58%…

Pharmana Wider View Vol.2 – Cardiovascular Disease

Pharmaceutical Stock Market Analaytics

Iranian Pharmaceutical Market and Industry Analysis

There are thousands of us now!

The visit of ministry of health from Hese-Mehr

Pharmana Wider View Vol.1 – Dementia

Special Partners